In June 2000, families across America unknowingly exposed their newborns to mercury-laced vaccines while top federal health officials, agency leaders, and pharmaceutical executives met in seclusion to review internal data showing elevated risks of autism and other developmental disorders. The meeting — held at the remote Simpsonwood retreat in Georgia — prioritized industry liability and public perception over immediate safety warnings, allowing thimerosal-containing shots to continue for years while autism diagnoses surged.
Image: Brokline News - Vaccine
The Triggering Study and Its Alarming Numbers
A CDC analysis of Vaccine Safety Datalink records from over 100,000 children examined neurological outcomes in infants receiving hepatitis B vaccine with thimerosal (a mercury-based preservative) within the first 30 days versus those who did not. Preliminary findings showed a relative risk of 11.35 for autism in the vaccinated group — higher than the relative risk of lung cancer from smoking a pack of cigarettes daily for 20 years (around 10).
The data also linked thimerosal exposure to increased rates of:
Speech delays
Attention-deficit disorder
Hyperactivity
Autism and other neurological issues
Closed-Door Deliberations at Simpsonwood
From 1991 onward, CDC and FDA pushed additional thimerosal-containing vaccines for newborns — including hepatitis B shots often given within hours of birth. Credit: Kibble Facts
The CDC convened the two-day session without public notice or open attendance, inviting representatives from the FDA, NIH, WHO, HHS, and major manufacturers including GlaxoSmithKline, Merck, Wyeth, and Aventis Pasteur. The isolated location along the Chattahoochee River helped avoid FOIA requests and media scrutiny.
Transcripts — later obtained via Freedom of Information Act — reveal participants acknowledging strong initial associations between thimerosal and neurodevelopmental harm. Robert F. Kennedy Jr., who reviewed the documents in 2005, described the discussion as devastating: officials viewed the science as “100% bulletproof” yet focused on managing fallout for the vaccine industry rather than immediate removal of the preservative.
Instead of alerting parents or halting distribution, much of the meeting centered on protecting the industry's bottom line and controlling the narrative around the data.
Congressional Probes Reveal Conflicts and Inaction
Rep. Dan Burton's House Government Reform Committee conducted a three-year investigation into thimerosal after his own grandson developed autism symptoms post-vaccination. The committee's final report concluded that “Thimerosal used as a preservative in vaccines is directly related to the autism epidemic,” accusing agencies of “institutional malfeasance for self-protection” and favoring pharmaceutical interests.
The probe uncovered financial ties among advisers:
Dr. Sam Katz, committee chair on related vaccine matters, served as a paid consultant to major vaccine makers and helped develop the measles vaccine.
Dr. Neal Halsey received research funding and honoraria from companies tied to hepatitis B vaccine.
Four of eight CDC advisers approving rotavirus vaccine guidelines had financial connections to manufacturers developing competing versions.
A Senate investigation later dismissed some cover-up claims as unsubstantiated, but the Burton report highlighted how conflicts compromised independent oversight.
Escalating Diagnoses After Expanded Recommendations
From 1991 onward, CDC and FDA pushed additional thimerosal-containing vaccines for newborns — including hepatitis B shots often given within hours of birth. Autism prevalence climbed dramatically: from roughly 1 in 2,500 children to 1 in 36 by recent estimates, with 2022 CDC ADDM Network data showing 1 in 31 among 8-year-olds/
Thimerosal was phased out of most U.S. childhood vaccines by 2001 as a precautionary measure, though some flu formulations retained it until recent policy shifts. Autism rates kept rising post-removal, a fact used by critics to question the mercury link — yet the original exposure window aligns with the sharpest increases.
A Partial Victory Amid Ongoing Concerns
After President Trump appointed Robert F. Kennedy Jr. to a health advisory role early in his term, momentum grew to eliminate remaining mercury exposures in vaccines. The removal from routine childhood schedules stands as a concrete win against a known neurotoxin — one that should have happened sooner.
The Simpsonwood episode reveals how institutional priorities can delay action when evidence threatens powerful interests. Parents and children bore the human cost while agencies debated optics. Transparency and independent oversight remain essential to prevent future exposures that erode trust and harm the most vulnerable.
